{
  "docId": "019de075-2dc4-7413-a6ea-ecd3ab0cc295",
  "docSlug": "e0f48061a961c5e04d59dc15b9a47e3c",
  "documentTitle": "MindMed | Investor Presentation Deck | 36 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 17,
  "pageCount": 36,
  "prevPage": 16,
  "nextPage": 18,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "dense",
  "nDataPoints": 3,
  "notes": "The slide uses a timeline diagram to illustrate the study flow from randomization to follow-up.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-2dc4-7413-a6ea-ecd3ab0cc295/17",
  "deckHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295",
  "deckJsonHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295.json",
  "deckAnchorHref": "/decks/019de075-2dc4-7413-a6ea-ecd3ab0cc295#slide-17",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.55,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Study timeline showing weeks -4 to 10, randomization, dosing, and endpoints.",
      "attrs": null,
      "subkind": "timeline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d48709b7-fb29-497a-b8ef-69dd0c42e9e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.85
      },
      "kind": "source-note",
      "text": "Source: MindMed internal study documents. AISRS: Adult ADHD Investigator Symptom Rating Scale; ASRS: Adult ADHD Self-Report Scale; CAARS: Conners' Adult ADHD Rating Scales; CGI-S: Clinical Global Impression - Severity",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "59e57e8a-04fa-4b13-af7c-037e4f2b62f3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.65,
        "y": 0.22
      },
      "kind": "table",
      "text": "Study MMED007 | MM-120 for ADHD. Key Entry Criteria and Additional Endpoints.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dec973b2-82f0-49d7-8420-b3d4850e4cea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.03
      },
      "kind": "title",
      "text": "MM-120 | Phase 2a Attention-Deficit Hyperactivity Disorder (ADHD)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b0d5844-1c0d-4622-b96c-0ab8676d88aa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.5,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "Proof of concept study design seeks to explore potential clinical response in ADHD",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "43c455c3-d975-41d8-92fa-eccabeca8857",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "b6ad1516-9e37-4c58-a5e4-d731c6a37bca",
      "evidence": "table/data: Study MMED007 | MM-120 for ADHD. Key Entry Criteria and Additional Endpoints.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "c7719ed7-8a50-40a5-985d-06fe8d8e75fb",
      "evidence": "Timeline visualization of clinical trial phases and dosing",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}